Strona 1 od 39 wyniki
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates generally to the field of cancer treatment. More particularly, it concerns methods of generating DHA-containing lipid nanoparticles and their use in the treatment of cancer.
2. Description of Related Art
In recent
TECHNICAL FIELD
This invention relates to prostate cancer, and more particularly to methods and compositions for inhibiting the proliferation of prostate cancer cells.
BACKGROUND
The prostate gland is located between the bladder and the rectum and wraps around the urethra. The prostate is composed
BACKGROUND OF THE INVENTION
The present invention relates to the treatment of cancer with a parenteral nutritional supplement, particularly a supplement having a specific class of structured lipids as its primary fat source. Surprisingly, the supplement containing these structured lipids, when used
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates generally to a medicament for the treatment, including prevention, of cancer. In other aspects, the invention relates to methods of treatment for cancer and other diseases.
2. Description of the Related Art
Pre-1920 cancer
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention relates generally to a medicament for the treatment and prevention of cancer. In other aspects, the invention relates to methods of treatment for cancer and other diseases, including vascular diseases.
2. Description of the Related
The present invention relates to methods for the prevention and treatment of chronic inflammatory diseases, cancer, and involuntary weight loss. In the practice of the present invention patients are enterally administered HMB alone or alternatively in combination with eicosapentaenoic (20:5
TECHNICAL FIELD
The invention relates to therapeutic agents and methods for treating cancer, and especially for overcoming multidrug resistance, including multidrug resistance in cancer stem cells. In particular, the invention relates to nanoemulsion formulations and delivery systems for taxoid
This application relates to a composition for the prevention, stabilization, reversal and treatment of cancer. An orally ingested composition is provided which contains effective amounts of nutrients which have been demonstrated to provide unique health benefits. The formulation significantly
FIELD
This invention relates to medicine, cancer, chemotherapy, materials science and medical devices. In particular it relates to a method of treating solid tumors, especially those that are refractory to normal chemotherapy or radiation therapy.
BACKGROUND
Cancer is currently the second greatest
FIELD
This invention relates to medicine, cancer, chemotherapy, materials science and medical devices. In particular it relates to a method of treating solid tumors, especially those that are refractory to normal chemotherapy or radiation therapy.
BACKGROUND
Cancer is currently the second greatest
FIELD OF THE INVENTION
The invention relates generally to the fields of molecular genetics, molecular biology, and oncology.
BACKGROUND
Leukemia is a highly prevalent disease that signifies uncontrolled production of white blood cells. Currently, there is no cure for leukemia. Current therapies of
FIELD OF THE INVENTION
The invention relates generally to the fields of molecular genetics, molecular biology, and oncology.
BACKGROUND
Leukemia is a highly prevalent disease that signifies uncontrolled production of white blood cells. Currently, there is no cure for leukemia. Current therapies of
FIELD OF THE INVENTION
The invention relates generally to the fields of molecular genetics, molecular biology, and oncology.
BACKGROUND
Leukemia is a highly prevalent disease that signifies uncontrolled production of white blood cells. Currently, there is no cure for leukemia. Current therapies of
CROSS-REFERENCE TO RELATED APPLICATION
This application is related to Japanese Patent Application No. 2001-37115 filed on Feb. 14, 2001, whose priority is claimed under 35 USC .sctn. 119, the disclosure of which is incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
1. Field of
BACKGROUND OF THE INVENTION
Technical Field
The present invention relates to a liposome for treating cancer by including doxorubicin, a polyunsaturated fatty acid, and beta glucan in combination.
Description of the Related Art
The "background" description provided herein is for the purpose of